Subprocessors

Subprocessor	Subject matter	Nature and purpose of processing	Location of processing
AWS	Personal data used in preparing Avantect results	Infrastructure provider providing computing and storage	USA
Snowflake	Personal data associated with ordering Avantect test, results from test	Infrastructure provider providing database storage	USA
DBT Labs	Personal data associated with ordering Avantect test, results from test	Analytics to support Avantect test processing, QC and results reporting	USA
DocuSign	Personal data associated with ordering Avantect test	eSignature provider	USA
HighTouch	Personal data associated with ordering Avantect test, results from test	Software to transfer data between databases in support of order management	USA
LabVantage Solutions	Personal data associated with ordering Avantect test, results from test	Software to coordinate laboratory processing work, test QC and preparation of results report	USA
Microsoft	Personal data associated with ordering Avantect test	Data storage provider	USA
Salesforce	Personal data associated with ordering of Avantect test	Software for recording orders and their status	USA
Sigma Computing	Personal data associated with the ordering of Avantect test, the QC and processing of test, and from results of test	Software for visualizing data, used for QC and review	USA
NetSuite	Financial data associated with the ordering of the Avantect test	Software for invoicing and receiving payments	USA

Important information

The Avantect Pancreatic Cancer Test is an early detection test. The test does not establish a diagnosis of pancreatic cancer, and results should be considered in the context of other clinical criteria. Definitive diagnosis of pancreatic cancer usually requires a series of imaging scans, blood tests, and a biopsy. Not all pancreatic cancers will be detected. Some patients with pancreatic cancer may have a “Signal not detected” result. Some patients without pancreatic cancer may have a “Signal detected” result. False-negative and false-positive results are possible. A “Signal not detected” result does not guarantee that no pancreatic cancer is present. In some cases, no result is obtained. While this is very uncommon, it may be caused by shipping delays or when there is not enough cell-free DNA for the test in the patient’s blood. If this happens, we generally ask for a repeat blood sample for testing at no extra cost.

The test was developed in the ClearNote Health CLIA-certified (CLIA# 05D2249973) and CAP-accredited (CAP# 9219174) laboratory and has not been cleared or approved by the US Food and Drug Administration (FDA).